Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4-52P is the designation for a pseudogene related to U4 small nuclear RNA, specifically the 52nd locus annotated in the human genome. Pseudogenes are genetic sequences that resemble functional genes but are generally non-coding and not transcribed or translated into functional RNA or protein. Unlike functional U4 snRNA genes (such as RNU4-2), which are core components of the spliceosome and play essential roles in pre-mRNA splicing and have clinical implications in neurodevelopmental disease, RNU4-52P itself is a pseudogene without documented biological function, therapeutic relevance, or disease association. There are no known drugs, molecular interactions, or biomarker utilities related to RNU4-52P. Clarification on Confusion: There is significant recent interest in functional U4 snRNA genes (such as RNU4-2), as mutations in these can cause neurodevelopmental syndromes. However, RNU4-52P is a pseudogene and not part of these disease mechanisms. If your interest is in the functional U4 small nuclear RNA involved in disease (for example, RNU4-2), refer to that specific gene, not the pseudogene. Summary: RNU4-52P is not a functional gene, not a drug target, and does not have known biomedical relevance. If you intended information on a functional U4 snRNA gene, please specify RNU4-2 or a similar gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 52, pseudogene (RNU4-52P).